XOMA - XOMA says chief investment officer Sitko buys 1.75K shares October, 05 2023 10:46 AM XOMA Corporation 2023-10-05 10:46:01 ET More on XOMA Novartis ends development of pancreatic cancer asset licensed from XOMA XOMA Corporation: Playing The Drug Royalty Strategy Via Preferreds For further details see: XOMA says chief investment officer Sitko buys 1.75K shares